China’s Diagnosis-Related Group (DRG) and Disease-Point (DIP) payment reforms bundle what hospitals earn for a procedure into a single fixed amount determined by the patient’s diagnosis and procedure group. For surgical robots, this creates a structural economic question: if a robotic procedure costs more to perform than the DRG/DIP payment for that group, the hospital absorbs the difference. Understanding how robotic surgery interacts with these payment structures is essential context for the commercial trajectory of medical robotics in China.
What DRG and DIP Are
DRG (Diagnosis-Related Groups) is a case-mix payment system in which each hospital admission is assigned to a group based on the principal diagnosis, procedure, patient characteristics, and complications. Each group carries a fixed payment weight. The hospital receives payment determined by the group weight multiplied by a local base rate, regardless of the actual cost of the admission.
DIP (Disease-Point) is a Chinese variant of bundled payment developed during the reform period. It uses a larger number of more granular disease-procedure combinations, with each combination assigned a point value. Like DRG, DIP pays a fixed amount per case; the difference is in how groups are constructed and how points translate to payment.
According to the National Healthcare Security Administration (NHSA), the DRG/DIP payment reform has been implemented across hundreds of pilot and expanded cities since 2019, with Version 2.0 of the framework issued in 2024 broadening coverage and refining grouping methodology.
The Core Tension for Robotic Surgery
Robotic surgery typically involves higher procedure costs than open or conventional laparoscopic surgery for the same clinical indication, primarily because of:
- Capital amortization costs for the robot
- Per-procedure instrument costs (robotic instruments have limited reuse counts)
- Operating room time, which may be longer particularly during a learning curve period
Under a bundled payment system, if the DRG/DIP payment for a procedure group is set based on the average cost of all procedures in that group — including conventional non-robotic cases — then hospitals performing robotic procedures receive the same payment as hospitals performing conventional procedures, despite higher actual costs. This compresses hospital margins on robotic cases.
The practical effects include:
- Incentive to control per-case robotic instrument costs
- Preference for higher-throughput procedures where robotic volume offsets instrument costs
- Risk that hospitals reduce robotic procedure volumes if margins deteriorate
DRG Grouping and Robotic Procedures
A key structural question is whether robotic surgery cases are grouped separately from conventional surgery for the same diagnosis — or pooled together. If pooled, robotic cases are paid at the same rate as conventional cases. If grouped separately, robotic cases can be assigned a higher payment weight reflecting their cost structure.
The NHSA DRG 2.0 framework includes provisions for grouping based on procedure codes, and procedure-level distinctions within diagnosis groups are built into the coding architecture. Whether a specific hospital’s robotic procedure is captured in a distinct group depends on:
- Whether the hospital uses the correct robotic procedure codes in clinical documentation
- Whether the local DRG/DIP implementation has created distinct groupings for robotic procedures
- Whether the provincial or municipal medical security bureau has calibrated payment weights for robotic procedure groups
This creates significant geographic variation across China in how robotic surgery is actually reimbursed in practice.
The New Technology Exception Mechanism
Both DRG and DIP frameworks include a new technology procedure exception mechanism. Under this provision, procedures using technologies newly approved by NMPA — within a specified period after regulatory approval — may be exempt from standard bundled payment rules for a transitional period. During this window, hospitals can bill for new technology procedures on a cost-plus or fee-for-service basis rather than the bundled rate.
The 5% additional payment mechanism (where hospitals can apply for supplementary reimbursement for qualifying new technologies on top of the standard DRG/DIP payment) is documented in NHSA guidance as a mechanism to encourage adoption of innovative technologies while the payment system catches up to cost structures. Local implementation determines which devices qualify and for how long the exception applies.
For recently NMPA-approved surgical robots, this mechanism can provide a transitional reimbursement window that makes hospital economics more favorable during the initial adoption period. Once the exception window expires, the procedure rolls into the standard DRG/DIP grouping.
Impact on Hospital Decision-Making
For a hospital evaluating whether to adopt a robotic surgical system, the reimbursement analysis involves:
Current payment group assignment: What DRG/DIP group does the relevant procedure fall into at this hospital? Is there a distinct robotic procedure group, or will robotic cases pool with conventional cases?
Exception applicability: Does the system qualify for the new technology exception under current NHSA and local rules? If so, for how long?
Volume and cost modeling: At what procedure volume do per-case instrument costs, amortization, and revenue align? Higher case volume lowers per-case fixed cost, improving margin.
Indications with reimbursed specialties: Some specialties and indications have more favorable DRG/DIP group structures for robotic surgery than others. Hospitals may prioritize robotic programs in indications where payment structures are better aligned with costs.
The interaction between hospital procurement decisions, case-volume projections, and reimbursement structure is discussed in the context of the overall procurement process in Hospital Procurement Process for Surgical Robots in China.
Broader Policy Direction
The NHSA has signaled intent to progressively include robotic surgery within normal bundled payment structures as procedures mature and cost data accumulates. This means the transitional exception windows are designed to be temporary. As Chinese-made surgical robots — which typically have lower capital and instrument costs than imported alternatives — become more common, the cost structure underpinning DRG/DIP group weightings may shift.
For context on the domestic robot cost dynamic that underlies this policy trajectory, see Why China is Pivoting to Domestic Surgical Robots.
Frequently Asked Questions
Does every Chinese province implement DRG/DIP the same way?
No. The DRG/DIP framework is set nationally by the NHSA, but provincial and municipal medical security bureaus calibrate base rates and group weights locally. Whether specific robotic procedure codes have distinct DRG/DIP groups — and what payment weight they carry — varies by region.
How does a hospital know whether to use DRG or DIP coding for a robotic procedure?
China’s reform has two parallel tracks: DRG and DIP, implemented in different pilot and expanded cities according to NHSA guidance. A given hospital is subject to whichever system its local medical security bureau has implemented. The hospital’s billing department is responsible for applying the correct procedure codes.
What happens to hospital economics when a new technology exception expires?
When a device’s new technology exception period ends, the procedure reverts to standard DRG/DIP grouping. If the relevant procedure group’s payment weight has not been updated to reflect actual robotic procedure costs, hospital margins on those cases may tighten. This is one reason manufacturers and hospital associations submit cost data to NHSA to support weight recalibration.
Do robotic surgery patients pay anything out of pocket for the robotic component?
Out-of-pocket costs for patients depend on whether the procedure and its robotic component are within the covered benefit for the patient’s health insurance. In many cases, the consumable instrument costs for robotic surgery are only partially reimbursable or fall into a cost-sharing category. Patient co-payment structures vary by local insurance rule.
Is DRG/DIP reform affecting adoption of specific surgical robot types?
The reform creates differential incentives by procedure type and reimbursement group structure. Orthopedic robotic procedures (joint replacement, spine) and some urological procedures have been subject to DRG piloting in more mature stages. Emerging applications — such as flexible endoscopic or bronchoscopic robots — are more likely to be in transitional exception periods given their more recent NMPA approval dates.